Consent to the Distribution of a New Medicine

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto:

Schedule

*Product:*	Arexvy
Active Ingredient:	Recombinant respiratory syncytial virus pre-fusion F protein 120mcg
*Component 1:*
Dosage Form:	Powder for injection
*Component 2:*
Dosage Form:	Suspension for injection
New Zealand Sponsor:	GlaxoSmithKline NZ Limited
Manufacturers:	GlaxoSmithKline Biologicals SA (Wave Nord), Wavre, Belgium GlaxoSmithKline Vaccines SRL, Sovicille, Italy

Dated this 2nd day of April 2024.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).

Tags

Notice Number

Schedule